Floatz logo

DESIPRAMINE

Back Pain

US Department of Veterans AffairsSmall moleculePhase 2Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
89/ 100

Competitive context

12 Active assets in the Back Pain cohort.

Asset / SponsorPhaseRating
Oxycodone
Grünenthal GmbH
Phase 4BBB
Bxcl501
Medical College of Wisconsin
Phase 4BB
Glycopyrrolate
Medical College of Wisconsin
Phase 4BB
NEPENTHE
MedtronicNeuro
Phase 4BB
LIDOCAINE
Medical College of Wisconsin
Phase 4BB

View all 41 →

Same molecule, other indications

DESIPRAMINE is also rated in:

depressive disorderDormant
BB
Indicative ·
66 / 100
View asset →
major depressive disorderDormant
BB
Indicative ·
64 / 100
View asset →
irritable bowel syndromeDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →